AFRM Stock Clocks 4 Days In The Red: One Analyst Still Sees 13% Upside After Trimming Target
Affirm Holdings (AFRM) shares fell 0.3% in overnight trading, extending a four-day losing streak. Morgan Stanley lowered its price target to $79 but still sees 13% upside. Monness Crespi initiated coverage with a 'Buy' rating and a $90 target. Analysts expect Q1 revenue of $1.21B and EPS of $0.38. AFRM stock is down 6% YTD.
How this was made
The 30-second read
Why it matters
Analyst coverage changes provide fresh guidance ahead of the Q1 earnings release, offering a short‑term trading cue.
Market read
Target adjustments ahead of earnings provide a modest trading signal; the stock’s near‑term direction hinges on the upcoming earnings report and broader rate‑policy environment.
What to watch
Potential Fed rate decision impact on consumer credit demand could outweigh the analyst target change.
Background
Affirm is a fintech firm offering buy‑now‑pay‑later services; its stock has slipped 0.3% after four losing sessions amid rate‑sensitivity concerns.
Ticker impact
Morgan Stanley trimmed its price target to $79 and Monness Crespi initiated coverage with a $90 target ahead of the Q1 earnings release.
modest downside as the market prices in the lower target, though upside remains possible if earnings beat expectations
Analyst target cuts are fresh information, but the move is modest and the earnings report is still days away.
Market effects
Buy‑now‑pay‑later sector may see slight re‑rating as analysts adjust targets.
U.S. market participants tracking fintech earnings will note the target change.
Limited; primarily affects U.S. fintech investors.
Counterpoint
The target cut could be an over‑reaction; the stock may rally on the upcoming earnings beat.
Key entities
- companyAffirm Holdings Inc.
Buy‑now‑pay‑later fintech whose stock ticker is AFRM.
- analyst_firmMorgan Stanley
Reduced AFRM price target to $79.
- analyst_firmMonness Crespi
Initiated coverage with a $90 target.


